BioSpace News Archive

Biotech Beach

Autobahn Therapeutics Takes Aim at CNS Disorders with $76 Million Series B

This morning, the company officially launched with a Series B funding round backed by some of the biggest names in the life sciences, including Bristol Myers Squibb, Biogen and Pfizer.

June 9, 2020
·
2 min read
·
Alex Keown
Drug Development

Sarepta’s Gene Therapy for Limb-Girdle Muscular Dystrophy Shows Promise

On Monday, Sarepta Therapeutics announced positive results from a small study of SRP-9003, its gene therapy for limb-girdle muscular dystrophy Type 2E (LGMD2E).

June 9, 2020
·
4 min read
·
Mark Terry
Deals

Royalty Pharma Targeting $1.96 Billion IPO

In a regulatory filing, Royalty Pharma indicated plans to offer 70 million shares of stock at a target price range of $25 to $28 per share, which would result in raising up to $1.96 billion for its initial public offering.

June 9, 2020
·
3 min read
·
Mark Terry
Business

BIO 2020: Day 1 Kicked Off With New CEO, Focus on COVID-19

The annual Biotechnology Innovation Organization meeting kicked off Monday with the proverbial passing of the baton from longtime head Jim Greenwood to Michelle McMurry-Heath, who was tapped to take over the organization last month.

June 9, 2020
·
3 min read
·
Alex Keown
Study Shows One Protein May Be Key to Preventing Pancreatic Cancer Metastasis

A study published in the Journal of Experimental Medicine on Monday revealed new research that showed pancreatic cancer metastasis may be suppressible by inhibiting a protein that regulates cell movement.

June 9, 2020
·
3 min read
·
Krystle Vermes
Business

Personalization, Prediction and Prevention Drive the “Second Transformation of Medicine”

The healthcare system is innovating to address the pain points the pandemic revealed. Specifically, it is becoming more proactive, preventative and personalized.

June 9, 2020
·
4 min read
·
Gail Dutton
Deals

Brown University Award of $3.4M includes funds for IND and First Clinical Trial of ONC212

Philadelphia, PA – Oncoceutics announced a Brown University award of $3.4 million that will be used to support a group of research teams for preclinical research, IND-enabling studies and a first-in-human clinical trial for Oncoceutics’ imipridone ONC212.

June 9, 2020
·
3 min read
Business

Alphamab and Sanofi China Ink Strategic Collaboration on Breast Cancer

Alphamab Oncology, based in Suzhou, China, inked a collaboration deal with Sanofi (China) Investment Co. to advance clinical trials of Alphamab’s KN026 with Sanofi’s Taxotere (docetaxel) in HER2+ breast cancer.

June 9, 2020
·
3 min read
·
Mark Terry
Business

Innovent and Roche Partner to Develop Bispecific Antibodies and Cell Therapies for Cancer

Michael Yu, chairman and chief executive officer of Innovent Biologics, said the deal with Roche will help the company continue to move forward in the cellular therapy space.

June 9, 2020
·
2 min read
·
Alex Keown
Business

Lundbeck to Revamp R&D Strategy and Eliminate Up to 160 Jobs

Lundbeck stated that it is optimizing its research and development organization to strengthen and advance its pipeline.

June 9, 2020
·
2 min read
·
Krystle Vermes